A case of bilateral endolymphatic sac tumours is reported. In a patient with von Hippel-Lindau syndrome, tumour growth in the right cerebellopontine angle caused deafness. The tumour was removed and classified as a metastasis from a thyroid carcinoma. However, on thyroidectomy no primary neoplasm could be found. Eight years later a similar tumour was operated on in the left petrosal bone. Histological appearance, inumunocytochemical findings, and the clinical context gave evidence that the tumours had to be reclassified as endolymphatic sac tumoursxtremely rare entities. The report supports the hypothesis, suggested by the few earlier case reports, that endolymphatic sac tumours could be one of the inherent tumour manifestations in von Hippel-Lindau syndrome. (3 Neurol Neurosurg Psychiatry 1996;61:318-320) 
Most physicians think that von Hippel-Lindau syndrome is the rare, autosomal dominant coincidence of angiomatosis retinae and cerebellar hemangioblastoma.I In reality, however, only 20% of patients with the disease show this combination, and with a prevalence of 1:40 000 the syndrome is much less rare than commonly thought.2 Other associated lesions include pheochromocytoma, pancreatic and renal cysts, renal carcinoma, and cystadenoma of the epididymis. In Histologically, the diagnosis "metastasis of a follicular thyroid carcinoma" was made although no primary tumour was known. The tumour did not react with antibodies against thyreoglobulin and a metastasis into the temporal bone is unusual. Nevertheless, the histological appearance of the tumour (figure) suggested the diagnosis beyond reasonable doubt. However, no primary carcinoma could be detected after thyroidectomy a few weeks later. In 1992, eight years after thyroidectomy, the patient was operated on for a new tumour, now of the left temporal bone. Histopathologically, the tissue looked similar to the specimen from 1984, but it was much more solid, papillary structures were more prominent, and there were only occasional cysts filled with colloid (figure) Discussion Endolymphatic sac tumours are adenomas originating from the epithelium of the endolymphatic sac of the inner ear. They are of neuroectodermal origin and seem to be extremely rare. Accordingly, the entity has not yet been well defined. Heffner reported 20 cases and listed the histological criteria8 which we followed to establish the new diagnosis in our patient. In most of Heffner's cases, the neoplasms had to be reclassified after a primary diagnosis had turned out to be questionable. The only case in which intraoperative evidence proved the origin of the tumour from the endolymphatic sac has been reported by Hassard and coworkers in 1984.9 In at least three cases the primary diagnosis of a metastatic thyroid tumour has been made. Other diagnoses included plexus papilloma, tumours of the ceruminal glands, bone cysts, so-called "glandular tumours of mixed histology", paragangliomas, metastases of renal carcinoma, and carcinomas that were not further specified.8 10 If recognised as primary tumours of the ear they have often been misinterpreted as (papillary) middle ear tumours.9 12 In most references endolymphatic sac tumours are referred to as adenomas or low grade adenocarcinomas, although they show little pleomorphism and only few mitotic profiles. Their growth is locally invasive but metastases have not been reported. The tumours have a papillary and cystic texture. The epithelium lining the cysts is uniform, single layered, and cuboidal. Its border to the stroma is often blurred and the papillary structures can be differentiated to a variable degree. The cystic lumina can be filled with a colloid that stains positive in the periodic acid Schiff's reaction and negative for mucicarmin and thus resemble thyroid follicles. In some cases there are areas with clear cells with a central nucleus; the cells resembling plant cells. Many tumours show fibrotic, haemorrhagic, and regressive aspects.
Immunohistochemically, the tumours stain positive for cytokeratin, often for glial fibrillary acidic protein, and negative for protein S100, synaptophysin, and thyroglobulin.9
In our patient these diagnostic criteria were fulfilled, the first tumour being extreme in terms of the number of colloid filled structures. Both tumours stained negative for glial fibrillary acidic protein, synaptophysin, and thyroglobulin, but positive for cytokeratin.
The bilateral appearance of an endolymphatic sac tumour strongly supports the hypothesis of a superordinate pathogenetic principle. It has been suspected that endolymphatic sac tumours could be another pathogenetically linked manifestation among the lesions of von Hippel-Lindau syndrome. In our patient, however, molecular proof of this assumption could not be found.
Poe and coworkers have reported two cases of bilateral tumours of the inner ear in patients with von Hippel-Lindau syndrome.1" There exist other reports (for more references see Lo et al'2) of inner ear tumours in von HippelLindau syndrome. With the exception of that of Delisle et al, none of these explicitly mentions endolymphatic sac tumours.'3 However, Gaffrey et al have reported seven cases of aggressive papillary tumours of the middle ear in patients with von Hippel-Lindau syndrome. '4 As middle ear adenomas and aggressive papillary tumours of the middle ear are the most important differential diagnosis of endolymphatic sac tumours,'0'2 it remains to be examined which relation exists between these entities and tumours of the inner ear, particularly in cases of von Hippel-Lindau syndrome. Interestingly, already the first patient of von Hippel was found to have a tumour of the petrous bone that histologically resembled a metastasis (without a primary tumour) from a renal carcinoma.'5 16 As endolymphatic sac tumours are difficult to detect and the diagnosis might often be missed because the entity is still unknown, we report this single case here. We hope that clinicians will review the records of their patients with proved or suspected von Hippel-Lindau syndrome for hearing problems and tumours of the temporal bone and report clinical or molecular evidence for or against the idea that endolymphatic sac tumours could be an associated lesion in von Hippel-Lindau syndrome.
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